Unsure which model to choose for your Safety & Tox studies?
We got your back!
We got your back!
Lab4Paws has established strong collaborations with veterinary clinics in Europe. We source samples collected for diagnostics or therapeutic reasons and process them in our lab.
The wrong model risks inconclusive data and months of delays.
Reliable PBMCs for safety/tox and translational studies are scarce in Europe.
Erroneous decisions now can derail your preclinical strategy—and your budget.
Flawed data from the incorrect model puts your regulatory submission at risk.
Expensive PBMCs are useless if they don’t arrive on time or fit your study needs.
What’s Holding Back Your Preclinical Safety & Toxicity Studies?
Get unparalleled access to our high-quality PBMCs.
Guaranteed availability with short lead times in Europe.
Expert guidance to help you select the most relevant animal model.
The Right PBMCs. The Right Model. The Right Results.
Want to learn more?
Lab4Paws has established strong collaborations with veterinary clinics in Europe. We source samples collected for diagnostics or therapeutic reasons and process them in our lab.
Our Complementary Services
Serum, Plasma, Swabs, Urine, Feces and much more. All samples are complete with patient metadata, indication and treatment.
We isolate Dissociated Tumor Cells (DTC) and primary cells from healthy and diseased tissues according to your applications.
Do you need biospecimens for longer studies? We can establish tumor-derived cell lines for your application.
For Drug Discovery, Diagnostics and Toxicology Studies we isolate PBMCs from Dogs, Cats but also Monkey and Pig/Minipig.
Why CHOOSE US
Lab4Paws has established strong collaborations with specialized centers in Europe.
We source samples ethically and can deliver quickly.
Next day delivery if in stock, up to 2 weeks for new isolations
Custom characterization (RNAseq, IHC, FACS, qPCR and more)
Quick response and start-up
High Quality and Expertise
frequently asked questions
Why should I use PBMCs and where can I learn more about them?
PBMCs have become widely used in recent years and are now an established tool for safety and toxicology studies. They are also employed in a series of other preclinical experiments. You can learn more about animal PBMCs here
How do I know which PBMCs are right for my study?
You can find here more details on Beagle PBMCs, Pig/Minipig PBMCs, Cynomolgus PBMCs, Alpaca PBMCs, Llama PBMCs and Horse PBMCs. If you need help selecting the right sample, you can talk to our experts or learn more on this page to help you decide which PBMCs are right for your research.
What makes Lab4Paws PBMCs better than others?
We typically ship cells that are in stock within 2 days. New projects can be delivered within two weeks for beagle, monkey, pig/minipig and llama and three weeks for alpaca.
What lead times can I expect in Europe?
Lab4Paws has established strong collaborations with specialized centers in Europe. We make sure our PBMCs are of high quality. More importantly, we follow ethical and humane protocols to ensure animal welfare. If you have any question on our sourcing methods or you want to ask other questions, visit this page.
Do you already know which samples you need?
Click below to get your quote
References
Fuss, I. J., Kanof, M. E., Smith, P. D., & Zola, H. (2009). Isolation of whole mononuclear cells from peripheral blood and cord blood. Current protocols in immunology, Chapter 7, 7.1.1–7.1.8. https://doi.org/10.1002/0471142735.im0701s85
Lyu, M., Shi, X., Liu, Y., Zhao, H., Yuan, Y., Xie, R., Gu, Y., Dong, Y., & Wang, M. (2023). Single-cell transcriptome analysis of H5N1-HA-stimulated alpaca PBMCs. Biomolecules, 13(60). https://doi.org/10.3390/biom13010060
Riedhammer, C., Halbritter, D., & Weissert, R. (2016). Peripheral Blood Mononuclear Cells: Isolation, Freezing, Thawing, and Culture. Methods in molecular biology (Clifton, N.J.), 1304, 53–61. https://doi.org/10.1007/7651_2014_99
Yu, S., Xiong, G., Zhao, S., Tang, Y., Tang, H., Wang, K., Liu, H., Lan, K., Bi, X., & Duan, S. (2021). Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review). International journal of molecular medicine, 47(2), 444–454. https://doi.org/10.3892/ijmm.2020.4817
